GenomeNet

Database: UniProt
Entry: Q62930
LinkDB: Q62930
Original site: Q62930 
ID   CO9_RAT                 Reviewed;         554 AA.
AC   Q62930; Q62957;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   04-NOV-2026, entry version 153.
DE   RecName: Full=Complement component C9;
DE   Flags: Precursor;
GN   Name=C9;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=9212048; DOI=10.1203/00006450-199707000-00020;
RA   Lassiter H.A., Walz B.M., Wilson J.L., Jung E., Calisi C.R.,
RA   Goldsmith L.J., Wilson R.A., Morgan B.P., Feldhoff R.C.;
RT   "The administration of complement component C9 enhances the survival of
RT   neonatal rats with Escherichia coli sepsis.";
RL   Pediatr. Res. 42:128-136(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Hinchliffe S.J., Van den Berg C.W., Rushmere N.K., Morgan B.P.;
RT   "Cloning of rat C9: consequences for homologous restriction of
RT   complement.";
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Pore-forming component of the membrane attack complex (MAC),
CC       a multiprotein complex activated by the complement cascade, which
CC       inserts into a target cell membrane and forms a pore, leading to target
CC       cell membrane rupture and cell lysis (PubMed:9212048). The MAC is
CC       initiated by proteolytic cleavage of C5 into complement C5b in response
CC       to the classical, alternative, lectin and GZMK complement pathways (By
CC       similarity). The complement pathways consist in a cascade of proteins
CC       that leads to phagocytosis and breakdown of pathogens and signaling
CC       that strengthens the adaptive immune system (By similarity).
CC       Constitutes the pore-forming subunit of the MAC complex: during MAC
CC       assembly, C9 associates with the C5b8 intermediate complex, and
CC       polymerizes to complete the pore (By similarity).
CC       {ECO:0000250|UniProtKB:P02748, ECO:0000269|PubMed:9212048}.
CC   -!- ACTIVITY REGULATION: Membrane attack complex (MAC) assembly is
CC       inhibited by CD59, thereby protecting self-cells from damage during
CC       complement activation. CD59 acts by preventing incorporation of the
CC       multiple copies of C9 required for complete formation of the osmolytic
CC       pore. MAC assembly is also inhibited by clusterin (CLU) chaperones that
CC       inhibit polymerization of C9. {ECO:0000250|UniProtKB:P02748}.
CC   -!- SUBUNIT: Homooligomer; about 20 C9 chains oligomerize to give rise to a
CC       huge beta-barrel that forms a 100 Angstrom diameter pore in target
CC       membranes. Component of the membrane attack complex (MAC), composed of
CC       complement C5b, C6, C7, C8A, C8B, C8G and multiple copies of the pore-
CC       forming subunit C9. {ECO:0000250|UniProtKB:P02748}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:9212048}. Target
CC       cell membrane {ECO:0000269|PubMed:9212048}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P02748}. Note=Secreted as soluble monomer.
CC       Oligomerizes at target membranes, forming a pre-pore. A conformation
CC       change then leads to the formation of a 100 Angstrom diameter pore.
CC       {ECO:0000250|UniProtKB:P02748}.
CC   -!- TISSUE SPECIFICITY: Detected in blood serum (at protein level).
CC       {ECO:0000269|PubMed:9212048}.
CC   -!- DEVELOPMENTAL STAGE: Detected at low levels in neonate blood serum.
CC       Levels increase throughout the first three weeks after birth.
CC       {ECO:0000269|PubMed:9212048}.
CC   -!- PTM: Phosphorylation sites are present in the extracellular medium.
CC       {ECO:0000250|UniProtKB:P02748}.
CC   -!- SIMILARITY: Belongs to the complement C6/C7/C8/C9 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA96528.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U49071; AAB38023.1; -; mRNA.
DR   EMBL; U52948; AAA96528.1; ALT_INIT; mRNA.
DR   RefSeq; NP_476487.2; NM_057146.2.
DR   AlphaFoldDB; Q62930; -.
DR   SMR; Q62930; -.
DR   BioGRID; 250734; 1.
DR   FunCoup; Q62930; 136.
DR   STRING; 10116.ENSRNOP00000018545; -.
DR   GlyCosmos; Q62930; 3 sites, No reported glycans.
DR   GlyGen; Q62930; 4 sites.
DR   iPTMnet; Q62930; -.
DR   PhosphoSitePlus; Q62930; -.
DR   SwissPalm; Q62930; -.
DR   PaxDb; 10116-ENSRNOP00000018545; -.
DR   GeneID; 117512; -.
DR   KEGG; rno:117512; -.
DR   AGR; RGD:620319; -.
DR   CTD; 735; -.
DR   RGD; 620319; C9.
DR   eggNOG; ENOG502QWHM; Eukaryota.
DR   InParanoid; Q62930; -.
DR   OMA; AAEFQCE; -.
DR   OrthoDB; 10037824at2759; -.
DR   Reactome; R-RNO-977606; Regulation of Complement cascade.
DR   PRO; PR:Q62930; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005576; C:extracellular region; EXP:UniProtKB.
DR   GO; GO:0005579; C:membrane attack complex; ISS:UniProtKB.
DR   GO; GO:0044218; C:other organism cell membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0001906; P:cell killing; ISO:RGD.
DR   GO; GO:0006956; P:complement activation; ISS:UniProtKB.
DR   GO; GO:0160257; P:complement activation, GZMK pathway; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; ISO:RGD.
DR   GO; GO:0031640; P:killing of cells of another organism; ISO:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; ISO:RGD.
DR   GO; GO:0055085; P:transmembrane transport; IEA:GOC.
DR   CDD; cd00112; LDLa; 1.
DR   FunFam; 2.10.25.10:FF:000766; Complement component C9; 1.
DR   FunFam; 2.20.100.10:FF:000089; Complement component C9; 1.
DR   FunFam; 4.10.400.10:FF:000213; Complement component C9; 1.
DR   Gene3D; 2.10.25.10; Laminin; 1.
DR   Gene3D; 4.10.400.10; Low-density Lipoprotein Receptor; 1.
DR   Gene3D; 2.20.100.10; Thrombospondin type-1 (TSP1) repeat; 1.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR036055; LDL_receptor-like_sf.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR001862; MAC_perforin.
DR   InterPro; IPR020864; MACPF.
DR   InterPro; IPR020863; MACPF_CS.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   PANTHER; PTHR45742; COMPLEMENT COMPONENT C6; 1.
DR   PANTHER; PTHR45742:SF3; COMPLEMENT COMPONENT C9; 1.
DR   Pfam; PF00057; Ldl_recept_a; 1.
DR   Pfam; PF01823; MACPF; 1.
DR   PRINTS; PR00764; COMPLEMENTC9.
DR   SMART; SM00192; LDLa; 1.
DR   SMART; SM00457; MACPF; 1.
DR   SMART; SM00209; TSP1; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   SUPFAM; SSF57424; LDL receptor-like module; 1.
DR   SUPFAM; SSF82895; TSP-1 type 1 repeat; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01209; LDLRA_1; 1.
DR   PROSITE; PS50068; LDLRA_2; 1.
DR   PROSITE; PS00279; MACPF_1; 1.
DR   PROSITE; PS51412; MACPF_2; 1.
DR   PROSITE; PS50092; TSP1; 1.
PE   1: Evidence at protein level;
KW   Complement alternate pathway; Complement pathway; Cytolysis;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Immunity; Innate immunity;
KW   Membrane; Membrane attack complex; Reference proteome; Secreted; Signal;
KW   Target cell membrane; Target membrane; Transmembrane;
KW   Transmembrane beta strand.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..554
FT                   /note="Complement component C9"
FT                   /id="PRO_0000023607"
FT   TRANSMEM        233..240
FT                   /note="Beta stranded"
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   TRANSMEM        267..274
FT                   /note="Beta stranded"
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   TRANSMEM        376..383
FT                   /note="Beta stranded"
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   TRANSMEM        384..392
FT                   /note="Beta stranded"
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DOMAIN          40..93
FT                   /note="TSP type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          97..134
FT                   /note="LDL-receptor class A"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          136..518
FT                   /note="MACPF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00745"
FT   DOMAIN          519..549
FT                   /note="EGF-like"
FT   SITE            267..268
FT                   /note="Cleavage; by thrombin"
FT   CARBOHYD        261
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        409
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        423
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        41..76
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        52..86
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        55..92
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        99..110
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        105..123
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        117..132
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        140..179
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        382..413
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        519..535
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        522..537
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        539..548
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   CONFLICT        65
FT                   /note="I -> M (in Ref. 2; AAA96528)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        300
FT                   /note="K -> R (in Ref. 2; AAA96528)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   554 AA;  62281 MW;  9C885F76A1275649 CRC64;
     MASGVTITLA IAIFALEINA QAPEPTPREE PSADALLPID CRMSTWSQWS QCDPCLKQRF
     RSRSIEVFGQ FQGKSCADAL GDRQHCEPTQ ECEEVQENCG NDFQCETGRC IKRKLLCNGD
     NDCGDFSDES DCESDPRLPC RDRVVEESEL GRTAGYGINI LGMDPLGTPF DNEFYNGLCD
     RVRDGNTLTY YRKPWNVAFL AYETKADKNF RTENYEEQFE MFKTIVRDRT TSFNANLALK
     FTITEAPIKK VGVDEVSPEK NSSKPKDSSV DFQFSYFKKE NFQRLSSYLS QTKKMFLHVK
     GMIQLGRFVM RNRGVMLTTT FLDDVKALPV SYEKGEYFGF LETYGTHYSS SGSLGGLYEL
     IYVLDKASMK EKGVELSDVK RCLGFNLDVS LYTPLQTALE GPSLTANVNH SDCLKTGDGK
     VVNISRDHII DDVISFIRGG TRKQAVLLKE KLLRGAKTID VNDFINWASS LDDAPALISQ
     KLSPIYNLIP LTMKDAYAKK QNMEKAIEDY VNEFSARKCY PCQNGGTAIL LDGQCMCSCT
     IKFKGIACEI SKQR
//
DBGET integrated database retrieval system